[Ip-health] POLITICO Pro Morning Health Care: Italy's transparency push

James Love james.love at keionline.org
Fri Feb 15 06:08:04 PST 2019


On Fri, Feb 15, 2019 at 8:58 AM James Love <james.love at keionline.org> wrote:

> than the cost of an automobile, or in some cases more than the price of a
> house.  Drug manufacturers have plenty of opportunities to offer analysis
> of how to make adjustments for risks or capital costs, but the
>



> aggregated
>

Make that : dis-aggregated



> and raw data needs to be there for everyone else to make their own
> evaluation of the facts.  Making access to facts of R&D costs exclusive to
> drug developers is asking for trouble
>
>
>


More information about the Ip-health mailing list